M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totaling 60,397 shares, a decline of 60.3% from the December 31st total of 152,225 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily volume of 381,391 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 381,391 shares, the short-interest ratio is presently 0.2 days. Approximately 0.2% of the shares of the company are short sold.
Insider Transactions at M3-Brigade Acquisition V
In related news, major shareholder Fitzgerald & Co. Cantor purchased 3,529,081 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average price of $10.80 per share, with a total value of $38,114,074.80. Following the completion of the acquisition, the insider owned 7,779,865 shares in the company, valued at approximately $84,022,542. This represents a 83.02% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Hedge Funds Weigh In On M3-Brigade Acquisition V
A number of large investors have recently bought and sold shares of MBAV. Wolverine Asset Management LLC grew its stake in M3-Brigade Acquisition V by 258.3% in the 3rd quarter. Wolverine Asset Management LLC now owns 350,157 shares of the company’s stock valued at $3,694,000 after acquiring an additional 252,419 shares during the period. Alberta Investment Management Corp acquired a new position in M3-Brigade Acquisition V during the second quarter worth $27,943,000. Harraden Circle Investments LLC purchased a new position in M3-Brigade Acquisition V during the second quarter valued at $28,818,000. Meteora Capital LLC grew its position in shares of M3-Brigade Acquisition V by 259.8% in the second quarter. Meteora Capital LLC now owns 633,383 shares of the company’s stock valued at $7,151,000 after purchasing an additional 457,332 shares during the period. Finally, Magnetar Financial LLC purchased a new stake in shares of M3-Brigade Acquisition V during the second quarter worth about $26,254,000.
M3-Brigade Acquisition V Stock Up 0.5%
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.
Read Our Latest Research Report on M3-Brigade Acquisition V
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank?check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real?world data capabilities, combined with Brigade’s deep experience in credit and asset management.
See Also
- Five stocks we like better than M3-Brigade Acquisition V
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
